Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid TumorsHER2-positive Advanced Solid TumorsRecruitingEarly phase 12026-05-05NCT05245058

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Shanghai Pharmaceuticals Holding Co., Ltd20

17 results · Page 1 of 1

Swipe the table sideways for more columns.